APOLLOHOSP

Apollo Hospitals Enterprise Limited

Integrated healthcare group — multi-specialty hospitals, pharmacy distribution, digital health

Healthcare›Healthcare›Healthcare Services›Hospital

apollohospitals.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹7890.00
Market cap
1,13,437 Cr
Stock P/E
54.3
P/B
11.96
Dividend yield
0.3%
ROE (FY26)
19.5%
ROCE (FY26)
19.9%
Operating margin (FY26)
11.5%
Debt / equity (FY26)
0.60
OCF / EBITDA (FY26)
75.8%
OCF / EBITDA (3Y)
75.3%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Apollo Hospitals (Apollo Hospitals Enterprise) runs hospitals in India and, through group companies, diagnostics, retail health clinics, pharmacy distribution and digital health.

Company snapshot

1stBy market cap

Ranked among 24 companies in Hospital.

Segment mix

Reportable segments as of 2024-09-30 (Consolidated). Revenue share = segment revenue ÷ total revenue.

Largest segment: 52.2% of revenue

SegmentRevenue shareRevenuePBTAssets
Digital Health & Pharmacy Distribution
40.8%
2,282 Cr39 Cr3,354 Cr
Healthcare Services
52.2%
2,920 Cr581 Cr12,766 Cr
Others
0.0%
1 Cr-0.90 Cr29 Cr
Retail Health & Diagnostics
7.2%
404 Cr12 Cr1,258 Cr

What we see

Positives
  • ✓Return on equity of 19.5% — the company generates strong returns on shareholders' money.

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales4,847 Cr4,851 Cr4,944 Cr5,086 Cr5,589 Cr5,527 Cr5,592 Cr5,842 Cr6,304 Cr6,477 Cr6,606 Cr7,044 Cr
Operating expenses (approx.)4,219 Cr4,237 Cr4,303 Cr4,411 Cr4,774 Cr4,765 Cr4,823 Cr4,990 Cr5,362 Cr5,512 Cr5,595 Cr5,951 Cr
EBITDA628 Cr614 Cr641 Cr675 Cr816 Cr762 Cr770 Cr852 Cr941 Cr965 Cr1,011 Cr1,092 Cr
OPM %12.9%12.7%13.0%13.3%14.6%13.8%13.8%14.6%14.9%14.9%15.3%15.5%
Other income22 Cr28 Cr28 Cr37 Cr38 Cr64 Cr61 Cr40 Cr55 Cr53 Cr44 Cr49 Cr
Interest111 Cr113 Cr119 Cr116 Cr118 Cr110 Cr115 Cr108 Cr110 Cr113 Cr119 Cr120 Cr
Depreciation163 Cr167 Cr190 Cr177 Cr185 Cr185 Cr211 Cr215 Cr218 Cr219 Cr224 Cr235 Cr
Profit before tax379 Cr363 Cr368 Cr430 Cr557 Cr536 Cr516 Cr583 Cr675 Cr682 Cr722 Cr799 Cr
Tax %34.4%30.0%29.8%26.6%29.0%29.2%19.6%24.3%26.8%24.3%23.6%23.6%
Net profit249 Cr254 Cr258 Cr316 Cr396 Cr379 Cr415 Cr441 Cr494 Cr516 Cr551 Cr610 Cr
EPS (₹)₹16.20₹17.06₹17.65₹21.23₹26.34₹25.89₹27.10₹30.10₹33.19₹34.94₹36.82₹40.39

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales7,255 Cr8,243 Cr9,617 Cr11,247 Cr10,560 Cr14,663 Cr16,612 Cr19,059 Cr21,794 Cr25,229 CrSign in free for the trailing twelve months
Operating expenses (approx.)6,526 Cr7,450 Cr8,554 Cr9,660 Cr9,423 Cr12,478 Cr14,563 Cr16,669 Cr18,772 Cr21,459 CrSign in free for the trailing twelve months
EBITDA729 Cr793 Cr1,064 Cr1,587 Cr1,137 Cr2,185 Cr2,050 Cr2,391 Cr3,022 Cr3,769 CrSign in free for the trailing twelve months
OPM %10.0%9.6%11.1%14.1%10.8%14.9%12.3%12.5%13.9%14.9%Sign in free for the trailing twelve months
Other income22 Cr32 Cr31 Cr27 Cr45 Cr78 Cr90 Cr106 Cr200 Cr192 CrSign in free for the trailing twelve months
Interest257 Cr295 Cr327 Cr533 Cr449 Cr379 Cr381 Cr449 Cr459 Cr450 CrSign in free for the trailing twelve months
Depreciation314 Cr359 Cr396 Cr620 Cr573 Cr601 Cr615 Cr687 Cr758 Cr876 CrSign in free for the trailing twelve months
Profit before tax222 Cr171 Cr374 Cr657 Cr221 Cr1,585 Cr1,101 Cr1,381 Cr2,039 Cr2,661 CrSign in free for the trailing twelve months
Tax %41.0%65.3%46.4%34.3%38.2%30.1%23.3%32.3%26.2%24.7%Sign in free for the trailing twelve months
Net profit131 Cr60 Cr200 Cr432 Cr137 Cr1,108 Cr845 Cr935 Cr1,505 Cr2,003 CrSign in free for the trailing twelve months
EPS (₹)₹15.88₹8.44₹16.97₹32.70₹10.74₹73.42₹56.97₹62.50₹100.56₹135.04Sign in free for the trailing twelve months
Dividend payout %————28.0%3.9%30.5%23.6%18.5%14.6%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital70 Cr70 Cr70 Cr70 Cr72 Cr72 Cr72 Cr72 Cr72 Cr72 Cr
Reserves3,602 Cr3,624 Cr3,264 Cr3,270 Cr4,531 Cr5,573 Cr6,125 Cr6,864 Cr8,140 Cr9,408 Cr
Borrowings3,049 Cr2,897 Cr3,450 Cr3,279 Cr2,495 Cr2,636 Cr2,710 Cr3,162 Cr5,275 Cr5,659 Cr
Other liabilities1,180 Cr1,222 Cr2,264 Cr4,589 Cr4,120 Cr4,679 Cr5,186 Cr6,271 Cr6,729 Cr6,564 Cr
Total liabilities8,117 Cr7,812 Cr9,183 Cr11,339 Cr11,417 Cr13,214 Cr14,428 Cr16,753 Cr20,657 Cr22,197 Cr
Fixed assets (net)4,276 Cr3,630 Cr4,594 Cr7,052 Cr6,334 Cr7,235 Cr7,432 Cr8,541 Cr9,816 Cr11,039 Cr
CWIP347 Cr698 Cr822 Cr233 Cr212 Cr44 Cr602 Cr845 Cr771 Cr992 Cr
Investments415 Cr900 Cr468 Cr440 Cr1,348 Cr806 Cr578 Cr990 Cr2,490 Cr2,181 Cr
Loans & advances——8 Cr7 Cr5 Cr4 Cr6 Cr5 Cr5 Cr2 Cr
Inventories467 Cr539 Cr585 Cr738 Cr249 Cr432 Cr390 Cr460 Cr481 Cr542 Cr
Trade receivables748 Cr805 Cr1,023 Cr1,027 Cr1,331 Cr1,768 Cr2,234 Cr2,515 Cr3,016 Cr3,485 Cr
Cash & bank519 Cr247 Cr283 Cr381 Cr425 Cr583 Cr433 Cr506 Cr578 Cr811 Cr
Other assets1,346 Cr994 Cr1,401 Cr1,461 Cr1,512 Cr2,342 Cr2,753 Cr2,893 Cr3,501 Cr3,145 Cr
Total assets8,117 Cr7,812 Cr9,183 Cr11,339 Cr11,417 Cr13,214 Cr14,428 Cr16,753 Cr20,657 Cr22,197 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity576 Cr—905 Cr1,293 Cr1,273 Cr1,616 Cr1,377 Cr1,920 Cr2,136 Cr2,856 Cr
Cash from investing-975 Cr—-711 Cr-289 Cr-872 Cr-791 Cr-857 Cr-1,537 Cr-3,381 Cr-2,148 Cr
Cash from financing547 Cr—-215 Cr-909 Cr-340 Cr-768 Cr-633 Cr-311 Cr1,317 Cr-478 Cr
Net cash flow148 Cr—-20 Cr95 Cr61 Cr57 Cr-113 Cr72 Cr73 Cr230 Cr
Free cash flow (OCF − Capex)-161 Cr—226 Cr780 Cr978 Cr958 Cr249 Cr784 Cr424 Cr894 Cr

Ratios

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %6.9%8.7%10.1%17.6%9.2%23.0%16.0%17.5%17.9%19.9%
ROE %5.7%1.5%6.8%13.1%3.1%17.9%12.5%12.3%16.7%19.5%
Debtor days38413933464449485050
Inventory days125155129149565962686465
Days payable134136158183260221305352296270
Cash conversion cycle296010-1-158-119-194-236-182-154
OCF / EBITDA %79.0%—85.1%81.4%112.0%73.9%67.2%80.3%70.7%75.8%
OCF / EBITDA % (3 years)————91.6%85.2%79.4%74.2%72.8%75.3%
Debt / equity0.830.001.040.980.540.470.440.460.640.60
Current ratio2.231.511.171.301.791.731.301.131.541.06
Net debt / EBITDA3.470.002.981.831.820.941.111.111.551.29